Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126667961 | 12666796 | 1 | I | 20160805 | 20160819 | 20160819 | EXP | US-MLMSERVICE-20160802-0376812-1 | US-ACCORD-043213 | ACCORD | BIEBER AK, COHEN DE, STEIN JA. SYSTEMIC METHOTREXATE FOR PRURIGO NODULARIS AND KERATOACANTHOMAS IN ACTINICALLY DAMAGED SKIN. JAAD CASE REPORTS. 2016; 2(3): 269-271. | 80.00 | YR | F | Y | 0.00000 | 20160819 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126667961 | 12666796 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | U | 40716 | |||||||||||
| 126667961 | 12666796 | 2 | SS | MYCOPHENOLIC ACID. | MYCOPHENOLIC ACID | 1 | Y | 65416 | |||||||||||
| 126667961 | 12666796 | 3 | SS | TRIAMCINOLONE | TRIAMCINOLONE | 1 | U | 0 | |||||||||||
| 126667961 | 12666796 | 4 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | Y | 0 | |||||||||||
| 126667961 | 12666796 | 5 | C | ACITRETIN. | ACITRETIN | 1 | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126667961 | 12666796 | 1 | Eczema |
| 126667961 | 12666796 | 2 | Eczema |
| 126667961 | 12666796 | 3 | Eczema |
| 126667961 | 12666796 | 4 | Eczema |
| 126667961 | 12666796 | 5 | Eczema |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126667961 | 12666796 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126667961 | 12666796 | Condition aggravated | |
| 126667961 | 12666796 | Drug ineffective | |
| 126667961 | 12666796 | Keratoacanthoma | |
| 126667961 | 12666796 | Off label use | |
| 126667961 | 12666796 | Squamous cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |